Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF Maintenance After Rituximab in Pediatric Nephrotic Syndrome
NCT04531865Phase 3Withdrawn
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jan 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in nephrotic syndrome, sponsored by Children's Hospital of Fudan University. Planned start Jan 2021; status: withdrawn.
02
Drugs
mycophenolate mofetil
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT04531865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04531865.